ODSEI Chip: An Open 3D Microfluidic Platform for Studying Tumor Spheroid‐Endothelial Interactions
Advanced Science · 2025-04 · 12 (13)
DOI: 10.1002/advs.202410659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.01.2025. Verfasst von Jooyoung Ro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, South Korea. Hauptthemen laut MEDLINE: Spheroids, Cellular, Breast Neoplasms, Microfluidics, Endothelial Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Basic Science, South Korea, Ministry of Health and Welfare, South Korea.
Abstract (Originalsprache)
Current in vitro models of 3D tumor spheroids within the microenvironment have emerged as promising tools for understanding tumor progression and potential drug responses. However, creating spheroids with functional vasculature remains challenging in a controlled and high‐throughput manner. Herein, a novel open 3D‐microarray platform is presented for a spheroid‐endothelium interaction (ODSEI) chip, capable of arraying more than 1000 spheroids on top of the vasculature, compartmentalized for single spheroid‐level analysis of drug resistance, and allows for the extraction of specific spheroids for further analysis. As proof of concept, the crosstalk between breast cancer spheroids and vasculature is monitored, validating the roles of endothelial cells in acquired tamoxifen resistance. Cancer spheroids exhibited reduced sensitivity to tamoxifen in the presence of vasculature. Further analysis through single‐cell RNA sequencing of extracted spheroids and protein arrays elucidated gene expression profiles and cytokines associated with acquired tamoxifen resistance, particularly involving the TNF‐α pathway via NF‐κB and mTOR signaling. By targeting the highly expressed cytokines (IL‐8, TIMP1) identified, tamoxifen resistance in cancer spheroid can be effectively reversed. In summary, the ODSEI chip allows to study spheroid and endothelial interaction in various contexts, leading to improved insights into tumor biology and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, South Korea.
- Center for Algorithmic and Robotized Synthesis, Institute for Basic Science (IBS), Ulsan, 44919, South Korea.
ORCID-Profile: Yoon-Kyoung Cho
Förderung
- Institute for Basic Science, South Korea
- Ministry of Health and Welfare, South Korea
Zitieren
APA
Ro, J., Kim, J., Park, J., Choi, Y., & Cho, Y. K. (2025). ODSEI Chip: An Open 3D Microfluidic Platform for Studying Tumor Spheroid‐Endothelial Interactions. Advanced Science, 12(13). https://doi.org/10.1002/advs.202410659
Vancouver
Ro J, Kim J, Park J, Choi Y, Cho YK. ODSEI Chip: An Open 3D Microfluidic Platform for Studying Tumor Spheroid‐Endothelial Interactions. Advanced Science. 2025;12(13). doi:10.1002/advs.202410659
BibTeX
@article{Ro2025,
author = {Ro, Jooyoung and Kim, Junyoung and Park, Juhee and Choi, Yongjun and Cho, Yoon-Kyoung},
title = {ODSEI Chip: An Open 3D Microfluidic Platform for Studying Tumor Spheroid‐Endothelial Interactions},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {13},
doi = {10.1002/advs.202410659}
}
EUVIMED